X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1240) 1240
Book Review (272) 272
Publication (90) 90
Book Chapter (41) 41
Conference Proceeding (6) 6
Book / eBook (4) 4
Dissertation (4) 4
Magazine Article (2) 2
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (765) 765
pleiotropic effects (447) 447
humans (424) 424
statins (270) 270
animals (210) 210
pleiotropic effect (178) 178
biochemistry & molecular biology (173) 173
male (143) 143
pharmacology & pharmacy (140) 140
female (130) 130
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (130) 130
analysis (124) 124
microbiology (115) 115
pleiotropic drug-resistance (114) 114
genetics & heredity (113) 113
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (104) 104
pleiotropic (102) 102
cardiac & cardiovascular systems (101) 101
saccharomyces-cerevisiae (99) 99
saccharomyces cerevisiae - genetics (96) 96
expression (95) 95
mutation (95) 95
atherosclerosis (90) 90
inflammation (88) 88
plant sciences (88) 88
yeast (86) 86
c-reactive protein (85) 85
middle aged (84) 84
oxidative stress (84) 84
saccharomyces cerevisiae - drug effects (84) 84
proteins (79) 79
research (79) 79
statin (78) 78
biotechnology & applied microbiology (76) 76
peripheral vascular disease (72) 72
genes (71) 71
cholesterol (70) 70
gene expression (69) 69
phenotype (68) 68
nitric-oxide synthase (67) 67
physiological aspects (67) 67
atp-binding cassette transporters - genetics (66) 66
cell biology (66) 66
genetic aspects (66) 66
aged (65) 65
simvastatin (63) 63
atorvastatin (62) 62
antifungal agents - pharmacology (59) 59
multidrug-resistance (59) 59
life sciences (58) 58
genetics (56) 56
saccharomyces cerevisiae - metabolism (56) 56
gene (55) 55
treatment outcome (55) 55
fungal proteins - genetics (54) 54
molecular sequence data (54) 54
saccharomyces cerevisiae (54) 54
pleiotropic drug (53) 53
transcription factors - genetics (53) 53
risk factors (52) 52
atp-binding cassette transporters - metabolism (51) 51
drug resistance (51) 51
saccharomyces cerevisiae proteins - genetics (50) 50
gene-expression (49) 49
cardiovascular disease (47) 47
transcription factors - metabolism (47) 47
coa reductase inhibitors (46) 46
adult (45) 45
lipids (45) 45
coronary-heart-disease (44) 44
dna-binding proteins - genetics (44) 44
health aspects (44) 44
protein (44) 44
saccharomyces cerevisiae proteins - metabolism (44) 44
genetic research (43) 43
hypercholesterolemia - drug therapy (43) 43
mice (43) 43
multidrug resistance (43) 43
saccharomyces cerevisiae proteins (43) 43
endothelium, vascular - drug effects (42) 42
base sequence (41) 41
gene expression regulation, fungal (41) 41
amino acid sequence (40) 40
article (40) 40
pleiotropic drug resistance (40) 40
cells (39) 39
endothelial function (39) 39
genomics (39) 39
myocardial-infarction (39) 39
cardiovascular-disease (38) 38
fungal proteins - metabolism (38) 38
review (38) 38
coronary-artery-disease (37) 37
evolution (37) 37
low-density-lipoprotein (36) 36
transcription (36) 36
disease (35) 35
endocrinology & metabolism (35) 35
hypercholesterolemia (35) 35
quantitative trait loci (35) 35
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1172) 1172
German (28) 28
Russian (22) 22
Spanish (16) 16
Japanese (15) 15
Polish (14) 14
French (9) 9
Hungarian (4) 4
Chinese (3) 3
Slovenian (3) 3
Croatian (1) 1
Czech (1) 1
Korean (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Atherosclerosis, ISSN 0021-9150, 05/2019, Volume 284, pp. 266 - 266
Journal Article
by Jeong, HS and Hong, SJ and Cho, SA and Kim, JH and Cho, JY and Lee, SH and Joo, HJ and Park, JH and Yu, CW and Lim, DS
JACC-CARDIOVASCULAR INTERVENTIONS, ISSN 1936-8798, 08/2017, Volume 10, Issue 16, pp. 1646 - 1658
OBJECTIVES This study compared adenosine-associated pleiotropic effects of the 2 P2Y(12) receptor antagonists on vascular function, systemic inflammation, and... 
pleiotropic effect | prasugrel | ADENOSINE-FREE ASSESSMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | HORMONE-THERAPY | diabetic patients | ticagrelor | COMBINED INTRACORONARY PRESSURE | ANTIPLATELET THERAPY | DIAGNOSTIC-ACCURACY | acute coronary syndrome | ACUTE MYOCARDIAL-INFARCTION | CARDIOVASCULAR-DISEASE | FLOW VELOCITY INFORMATION | POSTMENOPAUSAL WOMEN | LESION SEVERITY | Prospective Studies | Non-ST Elevated Myocardial Infarction - physiopathology | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Acute Coronary Syndrome - physiopathology | Male | Purinergic P2Y Receptor Antagonists - adverse effects | Percutaneous Coronary Intervention - instrumentation | Anti-Inflammatory Agents - adverse effects | Time Factors | Seoul | Adenosine - adverse effects | Adenosine - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Non-ST Elevated Myocardial Infarction - therapy | Adult | Brachial Artery - physiopathology | Female | Brachial Artery - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Stents | Purinergic P2Y Receptor Antagonists - therapeutic use | Endothelial Progenitor Cells - metabolism | Platelet Aggregation Inhibitors - adverse effects | Non-ST Elevated Myocardial Infarction - blood | Endothelial Progenitor Cells - drug effects | Inflammation Mediators - blood | Treatment Outcome | Prasugrel Hydrochloride - adverse effects | Biomarkers - blood | Acute Coronary Syndrome - blood | Prasugrel Hydrochloride - therapeutic use | Cross-Over Studies | Diabetes Mellitus, Type 2 - blood | Adenosine - analogs & derivatives | Diabetes Mellitus, Type 2 - mortality | Acute Coronary Syndrome - therapy | Aged | Vasodilation - drug effects | Non-ST Elevated Myocardial Infarction - mortality | Percutaneous Coronary Intervention - adverse effects | Index Medicus
Journal Article
ATHEROSCLEROSIS, ISSN 0021-9150, 05/2019, Volume 284, pp. 266 - 266
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 07/2019, Volume 10, Issue 1, pp. 1 - 9
Recent analyses have shown educational attainment to be associated with a number of health outcomes. This association may, in part, be due to an effect of... 
INTELLIGENCE | MULTIDISCIPLINARY SCIENCES | PLEIOTROPIC GENETIC-VARIANTS | LOCI | HEALTH | INFERENCE | GENOME-WIDE ASSOCIATION | Randomization | Health risk assessment | Education | Cognitive ability | Smoking | Educational attainment | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2016, Volume 67, Issue 10, pp. 1211 - 1213
Journal Article
Pharmacological Research, ISSN 1043-6618, 09/2011, Volume 64, Issue 3, pp. 180 - 186
Statins, long known to be beneficial in conditions where dyslipidemia occurs by lowering serum cholesterol levels, also have been proposed for use in... 
Alzheimer disease | Pleiotropic functions | Statins | Statins as Janus molecules | OXIDATIVE STRESS | COA REDUCTASE INHIBITORS | CLINICAL-TRIAL COHORT | DRUG-INTERACTIONS | NITRIC-OXIDE SYNTHASE | MILD COGNITIVE IMPAIRMENT | CELL-DEATH | COENZYME Q | AMYLOID-BETA | PHARMACOLOGY & PHARMACY | AUTOIMMUNE-DISEASE | Fatty Acids, Monounsaturated - pharmacology | Lovastatin - pharmacology | Heptanoic Acids - therapeutic use | Humans | Heptanoic Acids - adverse effects | Neurodegenerative Diseases - drug therapy | Quinolines - pharmacology | Fluorobenzenes - pharmacology | Fatty Acids, Monounsaturated - therapeutic use | Fatty Acids, Monounsaturated - adverse effects | Pyrroles - adverse effects | Indoles - pharmacology | Pyrroles - therapeutic use | Heptanoic Acids - pharmacology | Lovastatin - therapeutic use | Lovastatin - adverse effects | Alzheimer Disease - drug therapy | Rosuvastatin Calcium | Pyrimidines - pharmacology | Cholesterol - metabolism | Sulfonamides - pharmacology | Atorvastatin Calcium | Pyrroles - pharmacology | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Indoles - adverse effects | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Indoles - therapeutic use | Fluorobenzenes - adverse effects | Quinolines - therapeutic use | Fluorobenzenes - therapeutic use | Quinolines - adverse effects | Alzheimer's disease | Neuroprotection | Neurotoxicity | Neurodegenerative diseases | statins | Dyslipidemia | Clinical trials | Age | Cholesterol | Index Medicus
Journal Article
Journal Article
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, ISSN 0099-2240, 05/2019, Volume 85, Issue 10
Journal Article